Carmat raises €15.5 million in IPO

Carmat SAS has raised €15.5 million in an initial public offering on the Alternext section of the NYSE-Euronext exchange in Paris to continue development of an artificial heart for patients with heart failure.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France